Lexeo Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -59.28M-66.39M-98.33M
Share-based Compensation 1.78M3.04M12.47M
Gains from Investment Securities 0.16M0.42M0.41M
Non-cash Items 20.13M
Cash from Operations -54.56M-59.50M-81.15M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.88M1.27M1.37M
Depreciation & Amortization (CF) 0.12M0.27M0.30M
Change in Working Capital
Change in Account Payables -0.43M-0.18M2.38M
Change in Accured Expenses 4.48M2.09M3.37M
Change in Taxes -0.02M-0.35M
Other Working Capital Changes 1.89M-1.41M1.69M
Investing Activities
Capital Expenditures 0.67M0.12M0.48M
Cash from Investing Activities -0.90M-0.17M-94.08M
Financing Activities
Other financing activities 1.78M3.04M12.47M
Cash from Financing Activities 0.19M103.79M88.78M
Additional items
Change in Cash -55.27M44.13M-86.45M
Free Cash Flow -55.23M-59.61M-81.63M
Net Cash Flow -55.27M44.13M-86.45M